DV
Dividend Vision

SANA — Sana Biotechnology Inc

Sana Biotechnology Inc (SANA)

Total return is -89.9% over the past 5.5 years, 206.4 points behind SPY at 116.5%. Its deepest 1-year drawdown was 54.7%.

SANA is an equity fund that holds shares in Sana Biotechnology Inc, a company focused on cellular and gene therapy development. The fund does not currently pay distributions and carries no reported expense ratio or asset under management data available. This structure appeals primarily to growth-oriented investors seeking exposure to innovative biotechnology rather than income-focused dividend investors.

SANA key facts

Asset type
Stock
Asset class
Equity
Inception date
02/04/2021
Last close
$3.55
Market cap
$873,835,584
Average volume
3701900.0
Beta
2.143
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.92